Skip to content

Inspirata Approved Partner

Introducing digital pathology demands the highest standards in delivery execution, service up-time, and support.  Rhodes Group, an approved Inspirata enterprise support partner, is helping laboratories realize the immediate opportunities for improved patient outcomes presented by digitization.


Rhodes Group bring over 20 years of experience in laboratory and hospital technology interoperability to the emerging domain of digital pathology. Rhodes Group IT services and technology solutions help diagnose problems, optimize core business, and maximize efficiency and revenue in your lab’s operational, financial, and clinical systems. By providing clinical professionals with a greater outlook of health beyond a single patient, your lab can help elevate their ability to heal.

Questions about the Inspirata and Rhodes Group partnership?


Healthcare providers committed to digitizing their histopathology workflow are now able to implement Dynamyx™ via leading laboratory technology specialists and approved Inspirata enterprise support partner, Rhodes Group.

Inspirata’s partnership with Rhodes Group is borne out of a shared commitment to interoperability and laboratory workflow optimization with the aim of reducing case turnaround times and accelerating the return of patient results.


Rhodes Group believe better care requires a collaborative approach and brings this philosophy to complex digital pathology technology implementation. We collaborate with your vendors, clinical experts, staff, internal IT resources and other stakeholders to ensure a comprehensive, streamlined implementation to maximize your digital pathology solution. Implementation scope may include:

  • Interface Builds and Configuration
  • Pathology and Laboratory Information System Integration
  • Digital Pathology Client Installation
  • Software Install
  • Scanner Integration
  • Vendor Management
  • System Architecture Design
  • Infrastructure Support

Rhodes Group is thrilled to partner with Inspirata.  The combination of our services and Inspirata’s digital pathology streamlines implementation and advances the successful adoption of this ground-breaking technology.

James Brown
CEO, Rhodes Group


Printed Material(s)

Partner Homepage

Media Coverage

Dynamyx is CE-marked per Annex III of Directive 98/79/EC on in vitro diagnostic medical devices.

In the USA, Dynamyx is for research use only (RUO) and not for use in diagnostic procedures.

Questions about the Inspirata and Rhodes Group partnership?

Inspirata Approved Partners